BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15353372)

  • 21. A protein methyl transferase, PRMT5, selectively blocks oncogenic ras-p21 mitogenic signal transduction.
    Chie L; Cook JR; Chung D; Hoffmann R; Yang Z; Kim Y; Pestka S; Pincus MR
    Ann Clin Lab Sci; 2003; 33(2):200-7. PubMed ID: 12817625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A peptide from the GAP-binding domain of the ras-p21 protein as well as azatyrosine block ras-induced maturation of Xenopus oocytes.
    Chung DL; Brandt-Rauf P; Murphy RB; Nishimura S; Yamaizumi Z; Weinstein IB; Pincus MR
    Biochem Biophys Res Commun; 1991 Dec; 181(3):1378-84. PubMed ID: 1764089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic and activated wild-type ras-p21 proteins induce different isoforms of protein kinase C in mitogenic signal transduction.
    Chie L; Qu Y; Chung D; Boutjdir M; Pincus MR
    J Protein Chem; 2003 Nov; 22(7-8):625-9. PubMed ID: 14714729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer.
    Bowne WB; Michl J; Bluth MH; Zenilman ME; Pincus MR
    Cancer Ther; 2007; 5B():331-344. PubMed ID: 18007958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytes.
    Ranginwale M; Smith S; Flom J; Chie L; Kanovsky M; Chung D; Friedman FK; Robinson RC; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
    Exp Cell Res; 2001 Sep; 269(1):162-9. PubMed ID: 11525649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic amino acid substitutions in the inhibitory rap-1A protein cause it to adopt a ras-p21-like conformation as computed using molecular dynamics.
    Chen JM; Brandt-Rauf PW; Pincus MR
    J Biomol Struct Dyn; 1996 Jun; 13(6):925-33. PubMed ID: 8832375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated conformations of the ras-gene-encoded p21 protein. 1. An energy-refined structure for the normal p21 protein complexed with GDP.
    Dykes DC; Brandt-Rauf P; Luster SM; Chung D; Friedman FK; Pincus MR
    J Biomol Struct Dyn; 1992 Jun; 9(6):1025-44. PubMed ID: 1637501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A protein kinase C inhibitor induces phenotypic reversion of ras-transformed pancreatic cancer cells and cooperatively blocks tumor cell proliferation with an anti- ras peptide.
    Way D; Smith S; Sivendran S; Chie L; Kanovsky M; Brandt-Rauf PW; Chung DL; Michl J; Pincus MR
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):429-37. PubMed ID: 12107546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
    Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
    Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural effects of the binding of GTP to the wild-type and oncogenic forms of the ras-gene-encoded p21 proteins.
    Monaco R; Chen JM; Friedman FK; Brandt-Rauf P; Chung D; Pincus MR
    J Protein Chem; 1995 Nov; 14(8):721-9. PubMed ID: 8747433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular dynamics analysis of the structures of ras-guanine nucleotide exchange protein (SOS) bound to wild-type and oncogenic ras-p21. Identification of effector domains of SOS.
    Chen JM; Friedman FK; Hyde MJ; Monaco R; Pincus MR
    J Protein Chem; 1999 Nov; 18(8):867-74. PubMed ID: 10839623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
    Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathways for activation of the ras-oncogene-encoded p21 protein.
    Pincus MR; Chung D; Dykes DC; Brandt-Rauf P; Weinstein IB; Yamaizumi Z; Nishimura S
    Ann Clin Lab Sci; 1992; 22(5):323-42. PubMed ID: 1524403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular dynamics on complexes of ras-p21 and its inhibitor protein, rap-1A, bound to the ras-binding domain of the raf-p74 protein: identification of effector domains in the raf protein.
    Chen JM; Monaco R; Manolatos S; Brandt-Rauf PW; Friedman FK; Pincus MR
    J Protein Chem; 1997 Aug; 16(6):619-29. PubMed ID: 9263124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the site of inhibition of oncogenic ras-p21-induced signal transduction by a peptide from a ras effector domain.
    Chie L; Chen JM; Friedman FK; Chung DL; Amar S; Michl J; Yamaizumi Z; Brandt-Rauf PW; Pincus MR
    J Protein Chem; 1999 Nov; 18(8):881-4. PubMed ID: 10839625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-dimensional structure and properties of wild-type and mutant H-ras-encoded p21.
    Wittinghofer A; Franken SM; Scheidig AJ; Rensland H; Lautwein A; Pai EF; Goody RS
    Ciba Found Symp; 1993; 176():6-21; discussion 21-7. PubMed ID: 8299426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agents.
    Amar S; Glozman A; Chung D; Adler V; Ronai Z; Friedman FK; Robinson R; Brandt-Rauf P; Yamaizumi Z; Pincus MR
    Cancer Chemother Pharmacol; 1997; 41(1):79-85. PubMed ID: 9443618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the predicted structures of loops in the ras-SOS protein bound to a single ras-p21 protein with the crystallographically determined structures in SOS bound to two ras-p21 proteins.
    Smith S; Hyde M; Pincus MR
    Protein J; 2005 Aug; 24(6):391-8. PubMed ID: 16323045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the site of inhibition of mitogenic signaling by oncogenic ras-p21 by a ras effector peptide.
    Chie L; Friedman FK; Kung HF; Lin MC; Chung D; Pincus MR
    J Protein Chem; 2002 Jul; 21(5):367-70. PubMed ID: 12206511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.